{"abstract":"The Food and Drug Administration (FDA) is announcing a public meeting on consumer-directed promotion of prescription drugs. The purpose of the meeting is to enable the agency and other persons and organizations to present the results of their research on consumer- directed promotion of prescription drug products through print, broadcast, and other types of media. FDA is particularly interested in hearing about research by other persons and organizations that provides insight into the effects that consumer-directed promotion has on the public health. The agency is also interested in research on the groups most affected by consumer-directed promotion, including patients, caretakers, physicians, physician assistants, nurses, pharmacists, managed care organizations, and insurers. Date and Time: The public meeting will be held on September 22, 2003, from 9 a.m. to 5 p.m., and on September 23, 2003, from 9 a.m. to 5 p.m. Presenters must send final electronic presentations in Microsoft PowerPoint, Microsoft Word, or Adobe Portable Document Format (PDF) to FDA by close of business on September 10, 2003. Persons interested in presenting research should send requests and abstracts in writing to the Division of Dockets Management (HFA-305), Food and Drug Administration, rm. 1061, 5630 Fishers Lane, Rockville MD, 20852, by close of business on August 29, 2003. Location: The public hearing will be held at the National Transportation Safety Board Boardroom and Conference Center, 429 L'Enfant Plaza, SW., Washington, DC 20594. (Phone: 202-314-6421; Metro: L'Enfant Plaza station on the green, yellow, blue, and orange lines). See: http://ntsb.gov/events/newlocation.htm. (FDA has verified the Web site address, but FDA is not responsible for any subsequent changes to the Web site after this document publishes in the Federal Register.) Registration and Requests for Presentation: No registration is required to attend the meeting. Seating will be on a first-come, first- served basis. If you wish to present research during the public meeting, please submit your request and an abstract of your presentation to the Division of Dockets Management (see Date and Time). Requests should be identified with the docket number listed in the heading of this document. Transcripts of the meeting will be available for review at the Division of Dockets Management. For Information Regarding This Notice: Rose Cunningham, Center for Drug Evaluation and Research (HFD-006), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-594-5468, e-mail: cunninghamr@cder.fda.gov. If you need special accommodations due to a disability, please inform the contact person.","action":"Notice of public meeting; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2003/08/12/03-20522.html","cfr_references":[],"citation":"68 FR 47920","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. 2003N-0344"],"dockets":[],"document_number":"03-20522","effective_on":null,"end_page":47923,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2003/08/12/03-20522.xml","html_url":"https://www.federalregister.gov/documents/2003/08/12/03-20522/consumer-directed-promotion-public-meeting","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/03-20522?publication_date=2003-08-12","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2003-08-12/03-20522/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":33,"last_updated":"2026-10-23 08:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2003-08-12/pdf/03-20522.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2003-08-12","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2003/08/12/03-20522.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":47920,"subtype":null,"title":"Consumer-Directed Promotion; Public Meeting","toc_doc":"Consumer-directed promotion of prescripton drugs","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":68}